CollPlant Biotechnologies Ltd. CLGN

$ 3.76 -4.81%

Annual report 2023
added 10-19-2024

CollPlant Biotechnologies Ltd. Income Statement 2011-2024 | CLGN

Annual Income Statement CollPlant Biotechnologies Ltd.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	59.7 M	73.9 M	163 M	74.2 M	28.4 M	18.4 M	-	4.84 M	-	-	-	-	-
Shares	11.4 M	11 M	9.97 M	6.89 M	4.99 M	4.38 M	-	889 K	-	-	-	-	-
Historical Prices	5.24	6.7	16.4	10.8	5.7	4.2	-	-	-	-	-	-	-
Net Income	-7.02 M	-16.9 M	237 K	-5.77 M	-11.2 M	-6.25 M	-6.01 M	-7.25 M	-4.78 M	-3.34 M	-4.73 M	-4.6 M	-
Revenue	-	-	15.6 M	6.14 M	2.32 M	18 M	480 K	75.9 K	-	-	-	-	-
Cost of Revenue	1.99 M	400 K	2 M	3 M	1.88 M	1.66 M	-	-	-	-	-	-	-
Gross Profit	8.97 M	-101 K	13.6 M	3.14 M	439 K	3.36 M	465 K	75.9 K	-	-	-	-	-
Operating Income	-7.51 M	-17.1 M	65 K	-5.6 M	-7.63 M	-4.24 M	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-6.41 M	-16 M	838 K	-4.94 M	-7.09 M	-3.9 M	-5.96 M	-7.15 M	-4.62 M	-3.29 M	-4.37 M	-4.29 M	-
Operating Expenses	-	-	-	8.73 M	8.07 M	8.48 M	6.44 M	7.24 M	-	-	-	-	-
General and Administrative Expenses	-	-	5.94 M	4.62 M	3.66 M	12.5 M	2.38 M	2.86 M	1.77 M	945 K	1.01 M	1.28 M	-

All numbers in USD currency

Quarterly Income Statement CollPlant Biotechnologies Ltd.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	10.8 M	-	10.2 M	-	6.96 M	-	6.96 M	-	5.67 M	-	4.66 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-3.04 M	-	-	-	-1.97 M	-	-	-	-1.25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	691 K	-	-	-	823 K	-	-	-	606 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	429 K	-	-	-	748 K	-	-	-	463 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	262 K	-	-	-	75 K	-	-	-	143 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-3.06 M	-	-	-	-1.91 M	-	-	-	-1.76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-3.06 M	-	-	-	-1.91 M	-	-	-	-1.76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	1.42 M	-	-	-	986 K	-	-	-	820 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency